Wuxi Pharmatech (cayman) (NYSE:WX)

Reported 2010 fourth quarter EPS of $0.28 vs. $0.21 estimate. 2011 revenue guidance is in line with analyst estimates of $400 million. Even though 2011 EPS is expected to be flat at $1.09,  seven out of the next eight quarters are forecast to grow nicely. We will track this stock closely. We need to inquire about the other income line, which contributed EPS of $0.39 to 2010 results.  WX is an ex- GeoBargain.  We will pull SAIC filings.

See outlook

See earnings review of all ChinaHybrids on our Blog.

Wuxi Pharmatech removed from the GeoBargain on the Radar List. PEG ratio is near 1 .

Added to the GeoBargain List on May 15, 2009 @ $6.35

Current Price: $16.15

Reached a high of $18.00 on November 30, 2009